Point72 Asset Management’s Eli Lilly LLY Stock Holding History

Point72 Asset Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$19.8M	Sell	21,500 -7,100	-25%	-$7.2M	0.03%	809
2025 Q4	$30.7M	Buy	28,600 +24,100	+536%	+$23M	0.03%	644
2025 Q3	$3.43M	Hold	4,500	–	–	0.01%	1222
2025 Q2	$3.51M	Buy	+4,500	New	+$3.5M	0.01%	1092
2024 Q2	–	Sell	-22,000	Closed	-$17.1M	–	2187
2024 Q1	$17.1M	Buy	22,000 +20,000	+1,000%	+$14.2M	0.04%	504
2023 Q4	$1.17M	Hold	2,000	–	–	﹤0.01%	1360
2023 Q3	$1.07M	Buy	+2,000	New	+$1.03M	﹤0.01%	1303
2017 Q2	–	Sell	-100,000	Closed	-$8.41M	–	929
2017 Q1	$8.41M	Buy	+100,000	New	+$8.01M	0.05%	434

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Point72 Asset Management's LLY Position: Q1 2026 in Review

Point72 Asset Management increased its Eli Lilly (LLY) stake by 41% in Q1 2026, buying an estimated $28.4M and bringing the position to 95,766 shares worth $88.1M. The position accounts for 0.11% of the portfolio, ranked #198.

Point72 Asset Management first reported a position in LLY in Q4 2014 and has held it in 34 quarters since. The position peaked at $195M in Q3 2020. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Point72 Asset Management held 95,766 shares of Eli Lilly worth $88.1M as of Q1 2026.
Point72 Asset Management bought 28,020 Eli Lilly shares in Q1 2026, an estimated $28.4M.
Eli Lilly made up 0.11% of Point72 Asset Management's portfolio in Q1 2026, its #198 holding.
Point72 Asset Management first reported a position in Eli Lilly in Q4 2014 and has held it in 34 quarters since.
Point72 Asset Management's Eli Lilly position peaked at $195M in Q3 2020.
4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.